About Index Trending news
Analyze
Top 50 Pricing
Orphazyme

Orphazyme

Work at Orphazyme? Add yourself to this profile

Orphazyme

Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disorders called lysosomal storage diseases.

Elsewhere

Alexa global traffic share

Latest funding Show all
Venture capital (Series B)
$24,000,000
Venture capital (Series A)
$20,000,000
Employees

Unknown size

Locations
HQ
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Orphazyme makes some noise.